China SFDA Seeks Public Comment On Change To Proposed Definition Of “New” Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Agency’s draft drug registration rules propose to eliminate China’s fast track approval process for certain types of drugs, including AIDS and oncologics.